04/30/2024
4:22 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:24 PM | Merrimack Pharmaceuticals (Filer)
| Form DEFA14A | |
03/22/2024
8:46 AM | Merrimack Pharmaceuticals (Filer)
| Form DEFA14A | |
03/21/2024
3:48 PM | Merrimack Pharmaceuticals (Filer)
| Form 10-K/A | |
03/21/2024
3:52 PM | Merrimack Pharmaceuticals (Filer)
| Form DEF 14A | |
03/07/2024
3:39 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:42 PM | Merrimack Pharmaceuticals (Subject)
| Form 425 | |
03/07/2024
11:29 AM | BlackRock Inc. (Filed by)
Merrimack Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/22/2024
3:46 PM | ADAR1 Partners, LP (Filed by)
Merrimack Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/13/2024
3:22 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
Merrimack Pharmaceuticals (Subject)
| Form SC 13G | |
12/28/2023
3:05 PM | Andersen Eric (Reporting)
Merrimack Pharmaceuticals (Issuer)
Western Standard LLC (Reporting)
WESTERN STANDARD PARTNERS LP (Reporting)
Western Standard Partners QP, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
5:59 PM | Andersen Eric (Reporting)
Merrimack Pharmaceuticals (Issuer)
Western Standard LLC (Reporting)
WESTERN STANDARD PARTNERS LP (Reporting)
Western Standard Partners QP, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
4:09 PM | Andersen Eric (Reporting)
Merrimack Pharmaceuticals (Issuer)
Western Standard LLC (Reporting)
WESTERN STANDARD PARTNERS LP (Reporting)
Western Standard Partners QP, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:36 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
3:36 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
4:25 PM | Merrimack Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
3:31 PM | Merrimack Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
